Inhibition of the SHV-1 β-lactamase by sulfones:: Crystallographic observation of two reaction intermediates with tazobactam

被引:78
作者
Kuzin, AP
Nukaga, M
Nukaga, Y
Hujer, A
Bonomo, RA
Knox, JR [1 ]
机构
[1] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA
[2] Dept Vet Affairs Med Ctr, Res Serv, Cleveland, OH 44106 USA
关键词
D O I
10.1021/bi0022745
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Two species resulting from the reaction of the SHV-1 class A beta -lactamase with the sulfone inhibitor tazobactam have been trapped at 100 K and mapped by X-ray crystallography at 2.0 Angstrom resolution. An acyclic form of tazobactam is covalently bonded to the catalytic Ser70 side chain, and a second species, a five-atom vinyl carboxylic acid fragment of tazobactam, is bonded to Ser130. It is proposed that the electron density map of the crystal is a composite picture of two complexes, each with only a single bound species. It is estimated that the two complexes exist in the crystal in approximately equal populations. Results are discussed in relation to the mechanism-based inhibition of class A beta -lactamases by the similar inhibitors sulbactam and clavulanic acid.
引用
收藏
页码:1861 / 1866
页数:6
相关论文
共 34 条
[21]   Kinetic analysis of an inhibitor-resistant variant of the OHIO-1 β-lactamase, an SHV-family class A enzyme [J].
Lin, S ;
Thomas, M ;
Shlaes, DM ;
Rudin, SD ;
Knox, JR ;
Anderson, V ;
Bonomo, RA .
BIOCHEMICAL JOURNAL, 1998, 333 :395-400
[22]   Molecular bases for interactions between beta-lactam antibiotics and beta-lactamases [J].
Massova, I ;
Mobashery, S .
ACCOUNTS OF CHEMICAL RESEARCH, 1997, 30 (04) :162-168
[23]   Catalytic properties of class A β-lactamases:: efficiency and diversity [J].
Matagne, A ;
Lamotte-Brasseur, J ;
Frère, JM .
BIOCHEMICAL JOURNAL, 1998, 330 :581-598
[24]   Refinement of macromolecular structures by the maximum-likelihood method [J].
Murshudov, GN ;
Vagin, AA ;
Dodson, EJ .
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 1997, 53 :240-255
[25]   AMORE - AN AUTOMATED PACKAGE FOR MOLECULAR REPLACEMENT [J].
NAVAZA, J .
ACTA CRYSTALLOGRAPHICA SECTION A, 1994, 50 :157-163
[26]   β-lactamase inhibitors [J].
Page, MGF .
DRUG RESISTANCE UPDATES, 2000, 3 (02) :109-125
[27]   The mechanism of catalysis and the inhibition of β-lactamases [J].
Page, MI ;
Laws, AP .
CHEMICAL COMMUNICATIONS, 1998, (16) :1609-1617
[28]   COMPARATIVE ACTIVITIES OF CLAVULANIC ACID, SULBACTAM, AND TAZOBACTAM AGAINST CLINICALLY IMPORTANT BETA-LACTAMASES [J].
PAYNE, DJ ;
CRAMP, R ;
WINSTANLEY, DJ ;
KNOWLES, DJC .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1994, 38 (04) :767-772
[29]   Emergence of an inhibitor-resistant beta-lactamase (SHV-10) derived from an SHV-5 variant [J].
Prinarakis, EE ;
Miriagou, V ;
Tzelepi, E ;
Gazouli, M ;
Tzouvelekis, LS .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (04) :838-840
[30]   CHAIN - A CRYSTALLOGRAPHIC MODELING PROGRAM [J].
SACK, JS .
JOURNAL OF MOLECULAR GRAPHICS, 1988, 6 (04) :224-225